News|Articles|June 1, 2026

Exercise Program After Colon Cancer Chemotherapy Linked to Longer Survival and Lower Risk of Recurrence

Fact checked by: Spencer Feldman
Listen
0:00 / 0:00

Key Takeaways

  • Randomized data support structured post-adjuvant exercise as a disease-modifying survivorship strategy, improving disease-free survival and overall survival compared with education-only control.
  • Absolute recurrence-free survival gains at five years (80.3% vs 73.9%) corresponded to preventing one recurrence/new cancer/death per 16 participants.
SHOW MORE

Exercise after colon cancer chemotherapy reduced recurrence risk, improved survival and quality of life, according to the CHALLENGE trial.

A structured exercise program helped patients with colon cancer live longer, lowered the risk of their cancer returning and improved quality of life after treatment, according to findings presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting.

The results come from a new analysis of the phase 3 CHALLENGE trial, which examined the effects of a supervised exercise program in patients who had completed adjuvant chemotherapy for colon cancer. Researchers found that patients who participated in the program experienced meaningful improvements in both disease-free survival and overall survival compared with those who received health education materials alone.

Presenting the findings was Dr. Kelvin Chan, a medical oncologist and health economist at Sunnybrook Odette Cancer Centre and the University of Toronto, who said the results provide additional evidence that exercise can play an important role in recovery after cancer treatment.

"Following adjuvant chemotherapy for colon cancer, a structured exercise program improves disease-free survival and overall survival," Chan said during his presentation.

Exercise Reduced the Risk of Cancer Returning

One of the biggest concerns many patients face after completing treatment is whether their cancer will come back.

In the CHALLENGE trial, patients who participated in the exercise program were less likely to experience a recurrence, develop a new cancer or die compared with patients who received educational materials alone.

Five years after joining the study, 80.3% of patients in the exercise group remained free from cancer recurrence compared with 73.9% of patients in the comparison group.

According to Chan, that difference translates into one recurrence or new cancer diagnosis being prevented for every 16 patients who participate in the program.

For patients, those numbers suggest that exercise may do more than improve overall health and fitness. It may also help reduce the likelihood of the cancer returning after treatment.

Patients in the Exercise Program Lived Longer

Researchers also found a survival benefit among patients who participated in the structured exercise intervention.

Eight years after enrollment, 90.3% of patients in the exercise group were alive compared with 83.2% of patients who received health education materials.

Chan noted that approximately one death was prevented for every 14 patients who participated in the exercise program.

The findings build on results from the CHALLENGE trial that were previously published in The New England Journal of Medicine and have since influenced major cancer treatment guidelines.

What Did the Exercise Program Involve?

The intervention was designed specifically for people recovering from colon cancer treatment.

Patients worked with qualified exercise specialists over a three-year period. Sessions included behavioral coaching, supervised exercise and strategies to help participants develop long-term physical activity habits.

During the first year, patients met with exercise specialists every two weeks. In years two and three, sessions occurred monthly.

The goal was not intense athletic training but helping participants gradually become more physically active and maintain those habits over time.

Patients Also Reported Better Quality of Life

In addition to helping patients live longer, the exercise program improved quality-adjusted life years, a measure that combines both length of life and quality of life.

Researchers found that patients in the exercise group gained additional quality-adjusted life years compared with those who received health education materials alone.

For many survivors, quality of life becomes increasingly important after treatment, particularly when dealing with fatigue, physical limitations or concerns about recurrence. The findings suggest that exercise may help patients not only live longer but also spend more of that time in better overall health.

"Despite its upfront cost, the structured exercise program improves quality-adjusted life years, is cost saving, and very cost effective," Chan said.

Why the Findings Matter for Patients

Exercise is increasingly being recognized as an important component of cancer survivorship care.

Since publication of the CHALLENGE trial, structured exercise programs have been incorporated into recommendations from organizations including the National Comprehensive Cancer Network (NCCN) and the European Society for Medical Oncology (ESMO).

The new analysis found that the program also reduced overall health care costs by lowering spending related to cancer recurrence and anticancer treatments. Researchers estimated a savings of approximately $1,589 per patient despite the upfront costs required to deliver the exercise program.

Chan said the findings support making structured exercise programs a routine part of care for patients recovering from colon cancer treatment.

"Our findings provide economic evidence to support the integration of structured exercise programs into routine clinical care," he said.

Although additional research is needed to understand how best to implement these programs in different health care settings, the results suggest that exercise may offer patients a practical way to improve their chances of remaining cancer-free, living longer and maintaining a better quality of life after treatment.

References

  1. Structured exercise program following adjuvant chemotherapy for colon cancer: a cost-utility analysis of the CHALLENGE trial (abstract 3507). Dr. Kelvin Chan et al. Presented at: 2026 ASCO Annual Meeting; May 29-June 2, 2026; Chicago, IL.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.